By Business/Source
Currency:USD
2023/Q1
Stock NameRevenueRatio
Multi-Pill Abuse Resistant (MPAR)481.28K60.95%
Trypsin Activated Abuse Protection(TAAP)/Opioid Use Disorder(OUD)308.36K39.05%
By Country/Region
No Data
US Stock MarketDetailed Quotes
Ensysce Biosciences (ENSC)
- 0.3206
- -0.0614-16.07%
Trading May 12 15:52 ET
2.97MMarket Cap-0.14P/E (TTM)
0.3582High0.3152Low3.26MVolume0.3309Open0.3820Prev Close1.09MTurnover35.13%Turnover RatioLossP/E (Static)9.28MShares2.750052wk High0.93P/B2.97MFloat Cap0.301052wk Low--Dividend TTM9.27MShs Float86364.0000Historical High--Div Yield TTM11.26%Range %0.3010Historical Low0.3339Avg Price1Lot Size
Ensysce Biosciences (ENSC) Revenue Breakdown Overview
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm